Brind.

Cidara Therapeutics was discussed alongside peer groups in the market, involving MRK.

1 report, 1 independent Updated Jul 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cidara Therapeutics was discussed alongside peer groups in the market, involving MRK.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Merck incurred losses due to charges related to the acquisition of Cidara Therapeutics.Sub-event
  2. Cidara Therapeutics discussed with peer groups in the market.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped